Table 4. IV rt-PA administration and change in occluded site in sequential imaging.
| Distal change in occluded site in sequential imaging (Group A) (n = 55) | No change in occluded site in sequential imaging (Group B) (N = 148) | P value | |
|---|---|---|---|
| IV rt-PA | 0.5 | ||
| Yes (n = 103) | 30 | 73 | |
| No (n = 100) | 25 | 75 | |
| Time interval between IV rt-PA and DSA | 7.7 (n = 30) | 8.6 (n = 73) | 0.7 |
| Time interval between randomization and DSA | 21.1 | 20.9 | 0.9 |
IV: intravenous, rt-PA: recombinant tissue plasminogen activator.